Related Experiment Video
Updated: May 5, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Quantitative and Qualitative MRI Assessment of Perivascular Spaces in Parkinson's Disease Patients
Evelina Stagisa1,2, Arturs Silovs1,2,3, Gvido Karlis Skuburs2
1Department of Radiology, Riga East University Hospital, Hipokrata Street 2, LV-1038 Riga, Latvia.
Abstract:
Background and Objectives: Enlarged perivascular spaces (ePVS) demonstrated by MRI have recently been associated with cerebral small vessel disease and glymphatic dysfunction, implicated in Parkinson's disease (PD) pathophysiology. This study aimed to quantify the burden of ePVS in PD patients versus healthy controls and to examine associations with cognitive performance. Materials and Methods: A total of 51 participants underwent 3T MRI, including a T2-weighted sequence. Twenty-one patients with Parkinson's disease and 21 age-matched healthy controls were included in the final analysis. The ePVS burden was assessed quantitatively by counting visible PVS in the basal ganglia and centrum semiovale, and qualitatively using Potter and Heier rating scales. Cognitive function was measured with the Montreal Cognitive Assessment (MoCA). Statistical analyses used Mann-Whitney U tests and Spearman correlations. Results: PD patients had significantly higher total PVS counts in the basal ganglia (84.8 vs. 48.0; p < 0.001) and centrum semiovale (290.6 vs. 143.9; p < 0.001). Potter scale ratings were higher in PD across regions (p ≤ 0.025). Largest per-slice PVS counts negatively correlated with MoCA scores in right basal ganglia (ρ = -0.362, p = 0.012) and bilateral centrum semiovale (right: ρ = -0.421, p = 0.003; left: ρ = -0.431, p = 0.002). Heier scale differences were significant only in the right centrum semiovale (p = 0.023). PVS diameters were larger in PD only in the centrum semiovale (right: p = 0.010; left: p = 0.040). Conclusions: In this cohort, increased ePVS burden in the basal ganglia and centrum semiovale was associated with cognitive impairment in PD patients. Qualitative and quantitative PVS assessment, notably the largest-per-slice counts, may serve as a sensitive, non-invasive imaging biomarker for neurodegeneration and cognitive decline in PD. Larger group studies and longitudinal data are needed to assess their prognostic value in the long term, as well as the development of automatic quantification applications for better reproducibility.
Insights
Parkinson's disease patients show increased enlarged perivascular spaces (ePVS) linked to cognitive decline. MRI-based ePVS quantification may serve as a biomarker for neurodegeneration in PD.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Enlarged perivascular spaces (ePVS) on MRI are linked to cerebral small vessel disease and glymphatic dysfunction.
- These factors are implicated in the pathophysiology of Parkinson's disease (PD).
Purpose of the Study:
- To quantify the burden of ePVS in PD patients compared to healthy controls.
- To investigate the association between ePVS burden and cognitive performance in PD.
Main Methods:
- 3T MRI with T2-weighted sequences was performed on 42 participants (21 PD patients, 21 controls).
- ePVS burden was assessed quantitatively (counts) and qualitatively (Potter and Heier scales).
- Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA).
Main Results:
- PD patients exhibited significantly higher total ePVS counts in the basal ganglia and centrum semiovale.
- Higher ePVS burden, particularly largest-per-slice counts, negatively correlated with MoCA scores in PD patients.
- Qualitative scales showed increased ePVS in PD, with significant differences noted in specific brain regions.
Conclusions:
- Increased ePVS burden in the basal ganglia and centrum semiovale is associated with cognitive impairment in Parkinson's disease.
- Quantitative and qualitative ePVS assessment may act as non-invasive imaging biomarkers for neurodegeneration and cognitive decline in PD.
- Further research with larger cohorts and longitudinal data is recommended to validate prognostic value and develop automated quantification.

